Literature DB >> 1921238

The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease.

J B Ubbink1, W J Vermaak, J M Bennett, P J Becker, D A van Staden, S Bissbort.   

Abstract

Total serum homocysteine and cholesterol levels were determined in 163 male patients with typical angina who were subjected to coronary angiography. The prevalence of homocysteinemia in coronary heart disease (CHD) was 41.9%. Serum homocysteine levels were significantly elevated (p less than 0.05) in patients with major occlusion in two or three coronary arteries. Furthermore, the prevalence of homocysteinemia correlated positively (p less than 0.05) with the number of coronary vessels that were occluded. The prevalence of hypercholesterolemia was 34.9%, but, in contrast to homocysteinemia, no graded strength of association with the number of stenotic coronary arteries could be demonstrated. The results suggest that homocysteinemia may contribute significantly to the development of coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1921238     DOI: 10.1007/bf01649290

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  36 in total

1.  Atherosclerosis. Scavenging for receptors.

Authors:  M S Brown; J L Goldstein
Journal:  Nature       Date:  1990-02-08       Impact factor: 49.962

2.  Homocysteinemia in rats induced by folic acid deficiency.

Authors:  J Y Lin; S S Kang; J M Zhou; P W Wong
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

3.  Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease.

Authors:  S S Kang; P W Wong; H Y Cook; M Norusis; J V Messer
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

4.  Is absence of atheroma in Down syndrome due to decreased homocysteine levels?

Authors:  B Chadefaux; I Ceballos; M Hamet; M Coude; M Poissonnier; P Kamoun; D Allard
Journal:  Lancet       Date:  1988-09-24       Impact factor: 79.321

Review 5.  A survey of 246 suggested coronary risk factors.

Authors:  P N Hopkins; R R Williams
Journal:  Atherosclerosis       Date:  1981 Aug-Sep       Impact factor: 5.162

Review 6.  Metabolism of sulfur-containing amino acids.

Authors:  M H Stipanuk
Journal:  Annu Rev Nutr       Date:  1986       Impact factor: 11.848

7.  Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase.

Authors:  S S Kang; J Zhou; P W Wong; J Kowalisyn; G Strokosch
Journal:  Am J Hum Genet       Date:  1988-10       Impact factor: 11.025

8.  Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor.

Authors:  S Parthasarathy
Journal:  Biochim Biophys Acta       Date:  1987-02-14

9.  PATHOLOGICAL FINDINGS IN HOMOCYSTINURIA.

Authors:  J B GIBSON; N A CARSON; D W NEILL
Journal:  J Clin Pathol       Date:  1964-07       Impact factor: 3.411

10.  Homocysteinemia due to folate deficiency.

Authors:  S S Kang; P W Wong; M Norusis
Journal:  Metabolism       Date:  1987-05       Impact factor: 8.694

View more
  10 in total

1.  Are plasma homocysteine and methionine elevated when binging and purging behavior complicates anorexia nervosa? Evidence against the transdiagnostic theory of eating disorders.

Authors:  S M Innis; C L Birmingham; E J Harbottle
Journal:  Eat Weight Disord       Date:  2009-12       Impact factor: 4.652

Review 2.  Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease.

Authors:  D A Stehouwer
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

Review 3.  Homocysteine, vitamins, and coronary artery disease. Comprehensive review of the literature.

Authors:  B V Taylor; G Y Oudit; M Evans
Journal:  Can Fam Physician       Date:  2000-11       Impact factor: 3.275

4.  Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.

Authors:  G L Booth; E E Wang
Journal:  CMAJ       Date:  2000-07-11       Impact factor: 8.262

5.  High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.

Authors:  Paul S Aisen; Lon S Schneider; Mary Sano; Ramon Diaz-Arrastia; Christopher H van Dyck; Myron F Weiner; Teodoro Bottiglieri; Shelia Jin; Karen T Stokes; Ronald G Thomas; Leon J Thal
Journal:  JAMA       Date:  2008-10-15       Impact factor: 56.272

6.  Hyperhomocysteinemia and the response to vitamin supplementation.

Authors:  J B Ubbink; A van der Merwe; W J Vermaak; R Delport
Journal:  Clin Investig       Date:  1993-12

7.  Risk factors for coronary heart disease in patients below 45 years of age.

Authors:  Mansoor Nadeem; Syed Shahzad Ahmed; Sarah Mansoor; Sidra Farooq
Journal:  Pak J Med Sci       Date:  2013-01       Impact factor: 1.088

8.  Insights in the regulation of trimetylamine N-oxide production using a comparative biomimetic approach suggest a metabolic switch in hibernating bears.

Authors:  Thomas Ebert; Johanna Painer; Peter Bergman; Abdul Rashid Qureshi; Sylvain Giroud; Gabrielle Stalder; Karolina Kublickiene; Frank Göritz; Sebastian Vetter; Claudia Bieber; Ole Fröbert; Jon M Arnemo; Andreas Zedrosser; Irene Redtenbacher; Paul G Shiels; Richard J Johnson; Peter Stenvinkel
Journal:  Sci Rep       Date:  2020-11-23       Impact factor: 4.379

9.  Association between plasma homocysteine and myocardial SPECT abnormalities in patients referred for suspected myocardial ischaemia.

Authors:  Alfred Ankrah; John Buscombe; Mike Machaba Sathekge
Journal:  Cardiovasc J Afr       Date:  2012-07       Impact factor: 1.167

10.  Elevated Plasma Homocysteine Concentration in Opium-Addicted Individuals.

Authors:  Mohammad Masoomi; Nahid Azdaki; Beydolah Shahouzehi
Journal:  Addict Health       Date:  2015 Summer-Autumn
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.